Zevra therapeutics appoints global medical leader, adrian quartel, m.d., ffpm, as chief medical officer

Celebration, fla., jan. 04, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra or the company), a rare disease therapeutics company, today announced the appointment of adrian quartel, m.d., ffpm, as chief medical officer. dr. quartel brings more than 20 years of experience in the international pharmaceutical industry with senior roles in clinical development, pharmacovigilance and medical affairs.
ZVRA Ratings Summary
ZVRA Quant Ranking